TRIGYN — Trigyn Technologies Balance Sheet
0.000.00%
- IN₹2.36bn
- -IN₹1.75bn
- IN₹8.98bn
- 84
- 87
- 49
- 88
Annual balance sheet for Trigyn Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,964 | 2,151 | 1,381 | 3,829 | 4,234 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,455 | 2,915 | 3,785 | 2,584 | 2,597 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,618 | 5,178 | 5,518 | 6,823 | 7,203 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 60.4 | 85.7 | 116 | 75.1 | 49.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,829 | 7,549 | 8,561 | 8,737 | 9,034 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,149 | 1,402 | 1,640 | 1,603 | 1,496 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,248 | 1,473 | 1,751 | 1,725 | 1,624 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 5,581 | 6,076 | 6,810 | 7,012 | 7,411 |
| Total Liabilities & Shareholders' Equity | 6,829 | 7,549 | 8,561 | 8,737 | 9,034 |
| Total Common Shares Outstanding |